Clinical Trials Browser

Phase 2 × zalutumumab × Head & Neck × Clear all

NCT00542308 2023-08-03

Zalutumumab in Non-curable Patients With SCCHN

Phase 2 Completed

90 enrolled 10 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell